Beam Therapeutics, founded in 2018, is at the forefront of genetic medicine innovation using CRISPR base editing to make precise, permanent edits to DNA without cutting strands. The company focuses on developing advanced gene therapies and precision medicines for treating serious diseases, including rare and genetic disorders. With a team of fearless innovators committed to rigorous research and open collaboration, Beam aims to provide life-long cures through groundbreaking technology.
Beam Therapeutics is seeking a Director of Regulatory Affairs – Advertising, Labeling, and Promotion to advance its clinical-stage genetic medicine program. This role involves leading all regulatory labeling activities for hematology programs, creating documentation, negotiating with regulatory agencies, and providing guidance on evolving global regulations. They value innovation and mentoring.
Beam Therapeutics, founded in 2018, is at the forefront of genetic medicine innovation using CRISPR base editing to make precise, permanent edits to DNA without cutting strands. The company focuses on developing advanced gene therapies and precision medicines for treating serious diseases, including rare and genetic disorders. With a team of fearless innovators committed to rigorous research and open collaboration, Beam aims to provide life-long cures through groundbreaking technology.